SG11201401082XA - Anti-viral compounds - Google Patents
Anti-viral compoundsInfo
- Publication number
- SG11201401082XA SG11201401082XA SG11201401082XA SG11201401082XA SG11201401082XA SG 11201401082X A SG11201401082X A SG 11201401082XA SG 11201401082X A SG11201401082X A SG 11201401082XA SG 11201401082X A SG11201401082X A SG 11201401082XA SG 11201401082X A SG11201401082X A SG 11201401082XA
- Authority
- SG
- Singapore
- Prior art keywords
- viral compounds
- viral
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161542056P | 2011-09-30 | 2011-09-30 | |
PCT/US2012/057562 WO2013049352A2 (en) | 2011-09-30 | 2012-09-27 | Anti-viral compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201401082XA true SG11201401082XA (en) | 2014-04-28 |
Family
ID=47996737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201401082XA SG11201401082XA (en) | 2011-09-30 | 2012-09-27 | Anti-viral compounds |
Country Status (14)
Country | Link |
---|---|
US (2) | US20140227321A1 (en) |
EP (1) | EP2748169A4 (en) |
JP (1) | JP2014528410A (en) |
KR (1) | KR20140071454A (en) |
CN (1) | CN103842364A (en) |
AU (1) | AU2012315988A1 (en) |
BR (1) | BR112014007781A2 (en) |
CA (1) | CA2862895A1 (en) |
HK (1) | HK1199028A1 (en) |
IL (2) | IL231781A0 (en) |
MX (1) | MX2014003889A (en) |
SG (1) | SG11201401082XA (en) |
TW (1) | TW201321385A (en) |
WO (1) | WO2013049352A2 (en) |
Families Citing this family (47)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8053440B2 (en) | 2007-02-01 | 2011-11-08 | Resverlogix Corporation | Compounds for the prevention and treatment of cardiovascular diseases |
NZ617779A (en) | 2009-03-18 | 2015-08-28 | Resverlogix Corp | Novel anti-inflammatory agents |
US8754114B2 (en) | 2010-12-22 | 2014-06-17 | Incyte Corporation | Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3 |
US8846656B2 (en) | 2011-07-22 | 2014-09-30 | Novartis Ag | Tetrahydropyrido-pyridine and tetrahydropyrido-pyrimidine compounds and use thereof as C5a receptor modulators |
US8940742B2 (en) | 2012-04-10 | 2015-01-27 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
EP3822273B1 (en) | 2012-06-13 | 2024-04-10 | Incyte Holdings Corporation | Substituted tricyclic compounds as fgfr inhibitors |
WO2014026125A1 (en) | 2012-08-10 | 2014-02-13 | Incyte Corporation | Pyrazine derivatives as fgfr inhibitors |
US9266892B2 (en) | 2012-12-19 | 2016-02-23 | Incyte Holdings Corporation | Fused pyrazoles as FGFR inhibitors |
SG10201708520YA (en) | 2013-04-19 | 2017-12-28 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors |
ES2821394T3 (en) | 2013-09-12 | 2021-04-26 | Alios Biopharma Inc | 7,8-dihydro-3H-pyrazino [1,2-b] pyridazin-3,5 (6H) -dione compounds and uses thereof |
MX2021012208A (en) | 2013-10-04 | 2023-01-19 | Infinity Pharmaceuticals Inc | Heterocyclic compounds and uses thereof. |
US9751888B2 (en) | 2013-10-04 | 2017-09-05 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
CA2943075C (en) | 2014-03-19 | 2023-02-28 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds for use in the treatment of pi3k-gamma mediated disorders |
US9708348B2 (en) | 2014-10-03 | 2017-07-18 | Infinity Pharmaceuticals, Inc. | Trisubstituted bicyclic heterocyclic compounds with kinase activities and uses thereof |
US10851105B2 (en) | 2014-10-22 | 2020-12-01 | Incyte Corporation | Bicyclic heterocycles as FGFR4 inhibitors |
CN107108610B (en) | 2014-12-30 | 2019-06-04 | 豪夫迈·罗氏有限公司 | For treating and preventing the new tetrahydropyridine and pyrimidine and tetrahydropyridine and pyridine compounds that hepatitis b virus infects |
MX2017010673A (en) | 2015-02-20 | 2018-03-21 | Incyte Corp | Bicyclic heterocycles as fgfr inhibitors. |
WO2016134294A1 (en) | 2015-02-20 | 2016-08-25 | Incyte Corporation | Bicyclic heterocycles as fgfr4 inhibitors |
MA41551A (en) | 2015-02-20 | 2017-12-26 | Incyte Corp | BICYCLIC HETEROCYCLES USED AS FGFR4 INHIBITORS |
CN107531717B (en) | 2015-03-11 | 2021-07-27 | 詹森生物制药有限公司 | Aza-pyridone compounds and uses thereof |
US10111885B2 (en) | 2015-03-13 | 2018-10-30 | Resverlogix Corp. | Compositions and therapeutic methods for the treatment of complement-associated diseases |
JP6462155B2 (en) | 2015-05-04 | 2019-01-30 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Tetrahydropyridopyrimidines and tetrahydropyridopyridines as inhibitors of HBsAg (HBV surface antigen) and HBV DNA production for the treatment of hepatitis B virus infection |
US10160761B2 (en) | 2015-09-14 | 2018-12-25 | Infinity Pharmaceuticals, Inc. | Solid forms of isoquinolinones, and process of making, composition comprising, and methods of using the same |
US10759806B2 (en) | 2016-03-17 | 2020-09-01 | Infinity Pharmaceuticals, Inc. | Isotopologues of isoquinolinone and quinazolinone compounds and uses thereof as PI3K kinase inhibitors |
WO2017214269A1 (en) | 2016-06-08 | 2017-12-14 | Infinity Pharmaceuticals, Inc. | Heterocyclic compounds and uses thereof |
JP6821716B2 (en) | 2016-06-29 | 2021-01-27 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | A novel dihydropyrrolopyrimidine for the treatment and prevention of hepatitis B virus infection |
JP6742452B2 (en) | 2016-06-29 | 2020-08-19 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | Novel tetrahydropyridopyrimidines for treatment and prevention of HBV infection |
AR111960A1 (en) | 2017-05-26 | 2019-09-04 | Incyte Corp | CRYSTALLINE FORMS OF A FGFR INHIBITOR AND PROCESSES FOR ITS PREPARATION |
CN112867716A (en) | 2018-05-04 | 2021-05-28 | 因赛特公司 | Solid forms of FGFR inhibitors and methods for their preparation |
CN112566912A (en) | 2018-05-04 | 2021-03-26 | 因赛特公司 | Salts of FGFR inhibitors |
WO2020123395A1 (en) | 2018-12-10 | 2020-06-18 | Ideaya Biosciences, Inc. | 2-oxoquinazoline derivatives as methionine adenosyltransferase 2a inhibitors |
WO2020185532A1 (en) | 2019-03-08 | 2020-09-17 | Incyte Corporation | Methods of treating cancer with an fgfr inhibitor |
WO2021007269A1 (en) | 2019-07-09 | 2021-01-14 | Incyte Corporation | Bicyclic heterocycles as fgfr inhibitors |
AU2020366006A1 (en) | 2019-10-14 | 2022-04-21 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
US11566028B2 (en) | 2019-10-16 | 2023-01-31 | Incyte Corporation | Bicyclic heterocycles as FGFR inhibitors |
KR20220131900A (en) | 2019-12-04 | 2022-09-29 | 인사이트 코포레이션 | Derivatives of FGFR inhibitors |
EP4069696A1 (en) | 2019-12-04 | 2022-10-12 | Incyte Corporation | Tricyclic heterocycles as fgfr inhibitors |
US11753413B2 (en) | 2020-06-19 | 2023-09-12 | Incyte Corporation | Substituted pyrrolo[2,1-f][1,2,4]triazine compounds as JAK2 V617F inhibitors |
WO2021257857A1 (en) | 2020-06-19 | 2021-12-23 | Incyte Corporation | Naphthyridinone compounds as jak2 v617f inhibitors |
KR20230057341A (en) | 2020-07-02 | 2023-04-28 | 인사이트 코포레이션 | Tricyclic urea compounds as JAK2 V617F inhibitors |
WO2022006456A1 (en) | 2020-07-02 | 2022-01-06 | Incyte Corporation | Tricyclic pyridone compounds as jak2 v617f inhibitors |
WO2022046989A1 (en) | 2020-08-27 | 2022-03-03 | Incyte Corporation | Tricyclic urea compounds as jak2 v617f inhibitors |
CN114524810B (en) * | 2020-11-21 | 2023-12-01 | 上海凌达生物医药有限公司 | Pyrimidine heterocyclic compounds, preparation method and application |
WO2022140231A1 (en) | 2020-12-21 | 2022-06-30 | Incyte Corporation | Deazaguaine compounds as jak2 v617f inhibitors |
AR125273A1 (en) | 2021-02-25 | 2023-07-05 | Incyte Corp | SPIROCYCLIC LACTAMS AS JAK2 INHIBITORS V617F |
US11939331B2 (en) | 2021-06-09 | 2024-03-26 | Incyte Corporation | Tricyclic heterocycles as FGFR inhibitors |
WO2023078252A1 (en) | 2021-11-02 | 2023-05-11 | Flare Therapeutics Inc. | Pparg inverse agonists and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000065885A (en) * | 1999-04-10 | 2000-11-15 | 최승주 | Antiviral pyrimidinedione derivatives and process for the preparation thereof |
CA2590294A1 (en) * | 2004-12-13 | 2006-06-22 | Sunesis Pharmaceuticals, Inc. | Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors |
WO2008107436A1 (en) * | 2007-03-06 | 2008-09-12 | Novartis Ag | Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions |
AU2008256727A1 (en) * | 2007-05-23 | 2008-12-04 | Siga Technologies, Inc. | Antiviral drugs for treatment or prevention of dengue infection |
CA2709784A1 (en) * | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
SI2937350T1 (en) * | 2008-04-23 | 2018-05-31 | Gilead Sciences, Inc. | 1' -substituted carba-nucleoside analogs for antiviral treatment |
MX2012012353A (en) * | 2010-04-23 | 2013-02-07 | Kineta Inc | Anti-viral compounds. |
EP2560652A4 (en) * | 2010-04-23 | 2013-08-14 | Kineta Inc | Anti-viral compounds |
-
2012
- 2012-09-27 BR BR112014007781A patent/BR112014007781A2/en not_active IP Right Cessation
- 2012-09-27 CA CA2862895A patent/CA2862895A1/en not_active Abandoned
- 2012-09-27 AU AU2012315988A patent/AU2012315988A1/en not_active Abandoned
- 2012-09-27 US US14/348,520 patent/US20140227321A1/en not_active Abandoned
- 2012-09-27 EP EP12837518.5A patent/EP2748169A4/en not_active Withdrawn
- 2012-09-27 SG SG11201401082XA patent/SG11201401082XA/en unknown
- 2012-09-27 MX MX2014003889A patent/MX2014003889A/en not_active Application Discontinuation
- 2012-09-27 CN CN201280047114.0A patent/CN103842364A/en active Pending
- 2012-09-27 KR KR1020147011234A patent/KR20140071454A/en not_active Application Discontinuation
- 2012-09-27 WO PCT/US2012/057562 patent/WO2013049352A2/en active Application Filing
- 2012-09-27 JP JP2014533321A patent/JP2014528410A/en not_active Withdrawn
- 2012-09-28 TW TW101136098A patent/TW201321385A/en unknown
-
2014
- 2014-03-27 IL IL231781A patent/IL231781A0/en not_active IP Right Cessation
- 2014-12-12 HK HK14112535.1A patent/HK1199028A1/en unknown
-
2015
- 2015-12-02 US US14/957,507 patent/US20160102099A1/en not_active Abandoned
-
2016
- 2016-01-11 IL IL243558A patent/IL243558A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2862895A1 (en) | 2013-04-04 |
CN103842364A (en) | 2014-06-04 |
HK1199028A1 (en) | 2015-06-19 |
WO2013049352A2 (en) | 2013-04-04 |
AU2012315988A1 (en) | 2014-04-10 |
US20140227321A1 (en) | 2014-08-14 |
IL243558A0 (en) | 2016-02-29 |
IL231781A0 (en) | 2014-05-28 |
EP2748169A4 (en) | 2015-06-17 |
BR112014007781A2 (en) | 2017-04-11 |
TW201321385A (en) | 2013-06-01 |
MX2014003889A (en) | 2014-12-10 |
EP2748169A2 (en) | 2014-07-02 |
JP2014528410A (en) | 2014-10-27 |
US20160102099A1 (en) | 2016-04-14 |
WO2013049352A3 (en) | 2013-07-11 |
KR20140071454A (en) | 2014-06-11 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL243558A0 (en) | Anti-viral compounds | |
IL222634A0 (en) | Anti-viral compounds | |
GB201109763D0 (en) | Compounds | |
GB201106395D0 (en) | Compounds | |
EP2651920A4 (en) | Anti-viral compounds | |
IL222633A0 (en) | Anti-viral compounds | |
EP2651926A4 (en) | Anti-viral compounds | |
EP2560636A4 (en) | Anti-viral compounds | |
EP2651927A4 (en) | Anti-viral compounds | |
EP2651928A4 (en) | Anti-viral compounds | |
GB201107197D0 (en) | Compounds | |
EP2651923A4 (en) | Anti-viral compounds | |
EP2651925A4 (en) | Anti-viral compounds | |
IL222635A0 (en) | Anti-viral compounds | |
EP2714693A4 (en) | Anti-viral compounds | |
HK1199029A1 (en) | Anti-viral compounds | |
EP2714035A4 (en) | Anti-viral compounds | |
EP2560635A4 (en) | Anti-viral compounds | |
GB201110938D0 (en) | Compounds | |
GB201105659D0 (en) | Compounds | |
ZA201903284B (en) | Anti-viral compounds | |
EP2560628A4 (en) | Anti-viral compounds | |
GB201107348D0 (en) | Novel anti-viral | |
GB201115827D0 (en) | Compounds | |
GB201115828D0 (en) | Compounds |